C
Carlo M. Croce
Researcher at Ohio State University
Publications - 1156
Citations - 199822
Carlo M. Croce is an academic researcher from Ohio State University. The author has contributed to research in topics: microRNA & Cancer. The author has an hindex of 198, co-authored 1135 publications receiving 189007 citations. Previous affiliations of Carlo M. Croce include University of Nebraska Medical Center & University of California, Los Angeles.
Papers
More filters
Journal ArticleDOI
MIR21 Drives Resistance to Heat Shock Protein 90 Inhibition in Cholangiocarcinoma
Andrea Lampis,Pietro Carotenuto,Georgios Vlachogiannis,Luciano Cascione,Somaieh Hedayat,Rosemary Burke,Paul A. Clarke,Else Bosma,Michele Simbolo,Aldo Scarpa,Sijia Yu,Rebecca Cole,Elizabeth C Smyth,Javier Fernandez Mateos,Ruwaida Begum,Blanka Hezelova,Zakaria Eltahir,Andrew Wotherspoon,Nicos Fotiadis,Maria Antonietta Bali,Chirag Nepal,Khurum Khan,Mark Stubbs,Jens C. Hahne,Pierluigi Gasparini,Vincenza Guzzardo,Carlo M. Croce,Suzanne A. Eccles,Matteo Fassan,Matteo Fassan,David Cunningham,Jesper B. Andersen,Paul Workman,Nicola Valeri,Nicola Valeri,Chiara Braconi,Chiara Braconi +36 more
TL;DR: In this article, the effects of HSP90 inhibitors on cells with disruption of the microRNA 21 (MIR21 or miRNA21) gene, cells incubated with MIR21 inhibitors, and stable cell lines with inducible expression of microRNA21 were investigated.
Journal ArticleDOI
Effects of Calorie Restriction and Diet-Induced Obesity on Murine Colon Carcinogenesis, Growth and Inflammatory Factors, and MicroRNA Expression
Susan Olivo-Marston,Stephen D. Hursting,Susan N. Perkins,Aaron J. Schetter,Mohammed A. Khan,Carlo M. Croce,Curtis C. Harris,Jackie A. Lavigne +7 more
TL;DR: It is concluded that the enhancing effects of DIO and suppressive effects of CR on colon carcinogenesis are associated with alterations in several biological pathways, including inflammation, IGF-1, and microRNAs.
Journal ArticleDOI
MicroRNA regulation of tumorigenesis, cancer progression and interpatient heterogeneity: towards clinical use
TL;DR: MicroRNAs' role as drivers or suppressors of the hallmarks of cancer during tumorigenesis and progression are discussed, in defining interpatient heterogeneity and the promise of therapeutic application.
Journal ArticleDOI
The structure and nucleotide sequence of the 5' end of the human c-myc oncogene
Rosemary Watt,Kazuko Nishikura,Jennifer Sorrentino,Abbas Ar-Rushdi,Carlo M. Croce,Giovanni Giac. Rovera +5 more
TL;DR: The structure and nucleotide sequence of the 5' end of the human c-myc oncogene is established, using a cloned genomic fragment isolated from a fetal liver library and cloned cDNA from the human leukemic cell line K562 to establish the position of two transcription initiation sites.
Journal ArticleDOI
Expression profiling of microRNA using oligo DNA arrays.
TL;DR: The protocol the authors used to work with a custom miRNA microarray platform including the oligo design strategy, the microarray printing protocol, the target-probe hybridization and the signal detection is described.